Revenue: The sum of all revenue fields included for a company's operating activities.
Pyxis Oncology, Inc. (PYXS) had Revenue of $16.15M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$16.15M |
$-77.33M |
|
$0.47M |
|
$15.67M |
|
$105.61M |
|
$-89.46M |
|
$9.96M |
|
$-79.50M |
|
$-79.50M |
|
$-77.33M |
|
$-77.33M |
|
$-77.33M |
|
$-77.33M |
|
$-89.46M |
|
$-92.59M |
|
58.45M |
|
58.45M |
|
$-1.32 |
|
$-1.32 |
|
| Balance Sheet Financials | |
$132.44M |
|
$9.90M |
|
$24.74M |
|
$157.18M |
|
$17.68M |
|
-- |
|
$18.75M |
|
$36.43M |
|
$120.75M |
|
$118.15M |
|
$120.75M |
|
59.97M |
|
| Cash Flow Statement Financials | |
$-57.67M |
|
$8.15M |
|
$59.33M |
|
$11.14M |
|
$20.95M |
|
$9.81M |
|
$12.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
97.06% |
|
-554.07% |
|
-554.07% |
|
-573.44% |
|
-492.35% |
|
-478.95% |
|
$-57.91M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
-- |
|
-- |
|
-64.04% |
|
-65.45% |
|
-49.20% |
|
-64.04% |
|
$2.01 |
|
$-0.99 |
|
$-0.99 |
|